Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuke Qianjin Capsule for Chronic Pelvic Pain
NCT03251560Phase 2Unknown
- Start
- Dec 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Fuke Qianjin in chronic pelvic pain (CPP). Primary endpoint: Visual Analogue Scale at 8 weeks. Status: unknown.
02
Drugs
Fuke Qianjin
03
Conditions
chronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT03251560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03251560.